StockNews.com started coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Free Report) (TSE:AEZ) in a report released on Wednesday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock.
Aeterna Zentaris Trading Up 0.3 %
NASDAQ AEZS opened at $3.71 on Wednesday. The firm has a market cap of $6.65 million, a price-to-earnings ratio of -0.25 and a beta of 1.55. The company has a 50 day moving average of $4.22 and a 200-day moving average of $5.96. Aeterna Zentaris has a 1-year low of $3.96 and a 1-year high of $12.00.
Aeterna Zentaris Company Profile
Further Reading
- Five stocks we like better than Aeterna Zentaris
- The Role Economic Reports Play in a Successful Investment Strategy
- Chinese Stocks Cool Off: Time to Buy the Dip in These 2 Stocks?
- What is a support level?
- Goldman Sachs Highlights 3 Top Short Squeeze Stocks to Watch
- What is a SEC Filing?
- Walmart is Up 56% YTD, Is it Still a Top Consumer Staples Stock?
Receive News & Ratings for Aeterna Zentaris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aeterna Zentaris and related companies with MarketBeat.com's FREE daily email newsletter.